One of the College of Pharmacy’s goals is to develop and nurture centers, institutes, and programs in areas of excellence. This goal arose from a conviction that centers, institutes, and other identified programs serve many purposes, ranging from providing public recognition for an area of excellence, to coordinating the efforts of many individual faculty around a common purpose, to drawing diverse faculty together from several disciplines to address an interdisciplinary problem. It is our belief that having these groups will advance our educational, research, and outreach missions.
Search for the University's 250 centers, institutes and interdisciplinary graduate programs here.
Centers, institutes and programs affiliated with the College of Pharmacy are listed below:
The Ambulatory Care Residency Program is a multi-site program partnering with health care organizations in several Minnesota communities. The program has emphasis areas focused on community clinic practice, rural pharmacy practice and leadership.
The Antibiotic Pharmacodynamic Research Institute is located at the University of Minnesota in the new McGuire Translational Research Facility. APRI is interested in characterizing the in vitro pharmacodynamics of antibiotics in development. In general, we conduct studies that systematically evaluate the pharmacodynamic profile of an agent.
The Center for Biotherapy web site is not yet available. Please contact Ron Sawchuk (612-624-0646 or sawch001@umn.edu) for further information about the Center.
The Center for Excellence in Critical Care (CECC) is an alliance of healthcare practitioners and researchers committed to improving the care and outcomes of the critically ill patient through research, education and outreach.
There is a wide variability in patient response to drugs. It is imperative to better understand this inherent variability and strive to choose and dose drugs more appropriately. The mission of the Center for Forecasting Drug Response is to offer core expertise in the pharmaceutical sciences to clinical investigators across the University of Minnesota that will facilitate advanced pharmacokinetic, pharmcodynamic and pharmacogenomic study design, data analysis and interpretation of results.
The Center for Orphan Drug Research is a new research center dedicated to drugs for rare (or "orphaned") diseases. In addition to scientific research, the Center includes education and policy development in its service mission.
The mission of the Epilepsy Research and Education Program is to generate, disseminate and apply knowledge about the causes, epidemiology, management and treatment of epilepsy and related seizure disorders.
The Institute for Therapeutics Discovery and Development conducts research and offers scientific services in the area of drug discovery and development. The Institute consists of the High-Throughput screening Core (assay development, protein-based, cell-based and high-content screening, BSL-3 facility, 250,000-compound library), Medicinal Chemistry Core, Lead and Probe Discovery Core, and Chemical Process Development Core (cGMP/API production, kilogram scale).
The Leadership Center has been established to promote leadership development in our current students, alumni and the pharmacists of Minnesota.
The fundamental purpose of the Peters Institute of Pharmaceutical Care is to
advance the practice of pharmaceutical care.
The mission of the PREPP Institute is ensuring access to affordable medications and medication management services that optimize health outcomes in rural and underserved communities
The PRIME Institute was established as an independent and global research, education and consulting organization whose mission is the study of the economic and policy issues to help to improve the access of the population to pharmaceuticals and pharmaceuticals services.